Navigation Links
Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Internationally
Date:11/24/2011

THE HAGUE, November 24, 2011 /PRNewswire/ --

ProQares - a leading provider of testing, evaluation and certification services for protective equipment against chemical hazards - announced today a partnership with U.S.-based Rapid Pathogen Screening, Inc. (RPS®) - a leading developer of point-of-care diagnostic tests, to deploy the RPS chemical nerve agent detector in numerous countries throughout the European and Asia Pacific regions.  

The RPS chemical nerve agent detector is the first-of-its-kind point-of-care diagnostic test for human exposure to chemical poisons in the blood, including Soman, Sarin, Tabun, and VX, and is capable of detecting low-level chemical nerve agent exposure in 10 minutes or less with only a simple finger-stick blood sample.

"The partnership with RPS complements ProQares' mission to contribute to the protection of humans against toxic threats by providing fast and reliable test results," said Jack van Hoof, Managing Director of ProQares. "Through the partnership, ProQares will support RPS in marketing the RPS chemical nerve agent detector to its worldwide network of government and industrial organizations."

"This partnership will accelerate the deployment of this break-through technology and ensure that governments and other organizations charged with protecting the public from a chemical weapons attack have the most sophisticated tools available," said Robert Van Dine, Chief IP and Government Affairs Officer for RPS.

In June, in his address to the NATO Conference on WMD Arms Control, Disarmament and Non-Proliferation, Ambassador Ahmet Uzümcü, director-general of the Organisation for the Prohibition of Chemical Weapons (OPCW), focused NATO on his concern that "the future use of chemical weapons in a conventional military sense is remote. The misuse, on the other hand, of toxic chemicals, especially in an asymmetric sense, appears to be the more likely scenario."

A single chemical attack in an urban commercial or residential setting can result in tens of thouy" timex="11/24/2011 2:37:52 AM" dirsub="(sands of people that require immediate d...)" id="22399" index="medicine" dir="Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Internationally" dir2="Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Inter..." keywords1=",medicine,advanced medical technology,medical laboratory technology,medical device technology,latest medical technology" keywords="Leading,Chemical,Weapons,Preparedness,Companies,Announce,Partnership,to,Deploy,Break-through,Diagnostic,Test,Internationally" description="sands of people that require immediate diagnosis and treatment. Treatm...In early 2012 RPS expects to apply the CE mark to the RPS chemical nerve agent detector and begin d... ..." url=u&"/medicine-technology-1/Leading-Chemical-Weapons-Preparedness-Companies-Announce-Partnership-to-Deploy-Break-through-Diagnostic-Test-Internationally-22399-2/" title="Leading%20Chemical%20Weapons%20Preparedness%20Companies%20Announce%20Partnership%20to%20Deploy%20Break-through%20Diagnostic%20Test%20Internationally" %> Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Inter... ( THE HAGUE November 24 2011 /- Pro...)

Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Internationally
Date:11/24/2011

sands of people that require immediate diagnosis and treatment. Treatment for chemical weapon nerve agent exposure often is most effective within the first 40 minutes. The RPS chemical nerve agent detector responds to this need by providing a rapid, accurate and cost-effective diagnosis at the point-of-care.

In early 2012, RPS expects to apply the CE mark to the RPS chemical nerve agent detector and begin discussions with the U.S. Food and Drug Administration to bring it to market in the United States. The product is not currently CE-marked and is not yet available for sale in the United States.


'/>"/>
SOURCE ProQares
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PAREXEL Advances Early Phase CNS Research Capabilities With Leading Medical Imaging Technology
2. Qmed, the Leading Global MedTech Industry Resource Announces New Regulatory Tool to Streamline and Simplify the Regulatory and Product Development Process
3. United Spinal Secures Leading Public Policy and Durable Medical Equipment Specialist: Alex Bennewith is New Director of Government Relations
4. Leading Health Organizations and Patient Groups Call for 20 Percent Reduction in Fractures by 2020
5. Patients at Risk for Hepatitis B Are Not Adequately Screened Before Receiving Chemotherapy Leading to the Preventable Reactivation of Hepatitis B Infection
6. The Future of GPCRs in Drug Discovery: Novel technologies, leading companies, and opportunities for target expansion
7. Hypertronics Partners with UBM Canon, the Leading Global Medical Device Industry Source, to Co-Host Strategies for Avoiding Device Failure Seminar
8. American Skin Association Honors Leading Physicians and Scientists; Journalist Deborah Norville
9. Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search
10. Phreesia Continues to Enhance its Market-Leading Eligibility and Benefits Verification Process for Medical Practices
11. CADCA and Leading Makers of OTC Medicines Call Communities to Action During National Medicine Abuse Awareness Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017 Research and Markets has announced the ... report to their offering. ... The latest research Hemophilia Drugs Price Analysis and Strategies - 2016, ... The research answers the following questions: What ... are they positioned in the Global Hemophilia market? What ...
(Date:2/24/2017)... Feb. 24, 2017 Juan Monteverde , ... PC , a boutique securities firm headquartered at the ... , announces that a class action lawsuit has ...  against Inotek Pharmaceuticals Corporation (NASDAQ:  ITEK)("Inotek" or ... securities between July 23, 2015 and December 30, 2016, inclusive ...
(Date:2/24/2017)... Australia , Feb. 23, 2017  Directors from Pharma To ... two companies have joined forces, resulting in the founding of Pharma ... Pharma To Market are pleased to announce their expansion ... office in Singapore . The company are delighted ... as Co-Director of the Singapore based entity. ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... ... With ProGlass Prism users now have the ability to simulate prism distortions ... rotation, distortion, edge softness, edge blur, chromatic aberration, individual glass position offset, anchor point, ... users are given the tools and effects to generate a fractal prismatic displacement ...
(Date:2/24/2017)... ... ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced that he ... of the Management Committee when IFN was originally formed in 2002 where he was ... development of the business plan. He became the first paid employee of IFN ...
(Date:2/24/2017)... ... February 24, 2017 , ... Castle Farms, the celebrated ... Giveaway, with the winning couple announced on Feb. 14, 2017, on Facebook. The ... local vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch of Spring ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in Miami Beach to host its Swirl: Miami Wine Tasting Event on March ...
(Date:2/23/2017)... ... February 23, 2017 , ... Hamlin Dental Group and ... they are sponsoring a raffle. Throughout the month of February, patients who visit Hamlin ... gift card for a dinner for two at the Cheesecake Factory. , Tickets ...
Breaking Medicine News(10 mins):